410 reports of this reaction
2.1% of all RIMEGEPANT SULFATE reports
#8 most reported adverse reaction
FATIGUE is the #8 most commonly reported adverse reaction for RIMEGEPANT SULFATE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 410 FDA adverse event reports linking RIMEGEPANT SULFATE to FATIGUE. This represents approximately 2.1% of all 19,247 adverse event reports for this drug.
Patients taking RIMEGEPANT SULFATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for RIMEGEPANT SULFATE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for RIMEGEPANT SULFATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 410 FDA reports for RIMEGEPANT SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.1% of all adverse event reports for RIMEGEPANT SULFATE, making it a notable side effect.
If you experience fatigue while taking RIMEGEPANT SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.